Navigation Links
Medarex to Receive Milestone Payment from Novo Nordisk
Date:3/31/2008

PRINCETON, N.J., March 31 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX) today announced that it will receive a milestone payment for an undisclosed amount from its licensing partner, Novo Nordisk A/S. This payment is a result of the submission of an Investigational New Drug application by Novo Nordisk for the clinical development of an antibody generated by Medarex's UltiMAb(R) technology. Medarex may receive future milestone payments and royalties should this product candidate progress through clinical development and to the market.

"We are pleased with the milestone achieved by Novo Nordisk and look forward to continued development progress with this antibody," said Howard H. Pien, President and CEO of Medarex. "Product development advances of this type by Novo Nordisk and our other partners underpin the important role of our antibody technology in the development of new therapeutics."

Medarex is a biopharmaceutical company focused on the discovery, development and potential commercialization of fully human antibody-based therapeutics to treat life-threatening and debilitating diseases, including cancer, inflammation, autoimmune disorders and infectious diseases. Medarex applies its UltiMAb(R) technology and product development and clinical manufacturing experience to generate, support and potentially commercialize a broad range of fully human antibody product candidates for itself and its partners. More than 40 of these therapeutic product candidates derived from Medarex technology are in human clinical testing or have had INDs submitted for such trials, with seven of the most advanced product candidates currently in Phase 3 clinical trials or the subject of regulatory applications for marketing authorization. Me
'/>"/>

SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Medarex Receives Milestone Payment for Submission of Regulatory Application Requesting Approval of Golimumab (CNTO 148) in Europe for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
2. Medarex Announces Presentations at Annual Meeting of the American Association for Cancer Research
3. Medarex to Present at the Susquehanna Financial Group Healthcare Conference
4. Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008
5. Medarex Announces Completion of Sale of Shares in Genmab A/S
6. Medarex to Present at the 26th Annual JPMorgan Healthcare Conference
7. Medarex Announces Election of Marc Rubin as New Board Member
8. Medarex to Present at the UBS Global Life Sciences Conference
9. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
10. Medarex Announces Extension of Broad Antibody Development Relationship with Centocor
11. Medarex to Present at the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... FL (PRWEB) May 16, 2013 As the ... to showcase their favorite Spring looks. While most make a ... season. Unfortunately, many women find the warmer weather mixes makeup ... women cope with the onset of acne during warmer months, ... from female acne treatment users the best ways to deter ...
(Date:5/16/2013)... , May 16, 2013 ... research report is available in its ... Competitor Analysis: Therapeutic Proteins – ... http://www.reportlinker.com/p01171947/Competitor-Analysis-Therapeutic-Proteins-–-Biosimilars-Biobetters--Biosuperiors.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical   ... The new Competitive Intelligence ...
(Date:5/16/2013)... BioInformatics LLC New Market Report – ... Cells: Current and Future Opportunities (13-004) , With ... the primary cells market continues to increase. In this ... most often, how satisfied scientists are with commercially available ... growth rate. ,  , Additionally, terminally differentiated cells ...
(Date:5/16/2013)... 16, 2013 Dr. Stephen Y. Chou, ... titled “Nanoimprint Lithography and Applications” at IEEE Nano 2013 ... invented in 1995 by Chou, is becoming one of ... unique combination of sub-10 nm resolution, large area, and ... impacting both R&D and manufacturing in a broad range ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 2Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 3Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 4Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 5Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 6Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 7Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors 8BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3Founder, Prof. Stephen Chou to Give Tutorial on Nanoimprint at IEEE Nano 2013 2
... Mass., Sept. 30 NxStage Medical,Inc. (Nasdaq: NXTM ... that Jeffrey H. Burbank, Chief Executive Officer,and Robert S. ... JMP,Securities Healthcare Focus Conference on October 6, 2008 at ... presentation is scheduled for Monday, October 6th at,2:30 p.m. ...
... active U.S. Security ... ... today a new partnership that benefits those,career candidates with an active ... sites. The partnership includes,cross-promotion and delivery of online job postings, advertising, ...
... Inc. (OTC,Bulletin Board: BTEL) announced results for the year ... $0.23 per diluted share, on revenues of,$11,495,000. This compares ... revenues of $11,233,000 for the prior year. For its ... $0.07 per diluted share, on,revenues of $3,187,000. This compares ...
Cached Biology Technology:NxStage Medical to Present at JMP Securities Healthcare Focus Conference 2onTargetjobs and ClearedConnections Announce Online Recruitment Partnership 2Biotel Announces Record Revenues and Earnings for Fiscal 2008 2
(Date:5/16/2013)... MARC (Maximizing Access to Research Careers) Program has ... Society (ENDO) 95th Annual Meeting in San Francisco, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
(Date:5/16/2013)... Northwestern University scientists have shown a gene involved in ... proper function of the circadian clock. , In ... found the gene, called Ataxin-2, keeps the clock responsible ... the gene, the rhythm of the fruit fly,s sleep-wake ... schedule difficult for the fly. , The discovery ...
(Date:5/16/2013)... do so many sports players and athletes choose to ... study to be published in Psychological Science , ... that it may have to do with their testosterone ... Daniel Farrelly of the University of Sunderland and colleagues, ... in a competitive task had higher testosterone levels than ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2High-testosterone competitors more likely to choose red 2
... University researcher has created a compound that prevents replication of ... treatment for the disease. "The outbreak of SARS in ... and there is currently no treatment," said Arun Ghosh, the ... is not currently a threat, there is the concern that ...
... CHAPEL HILL Many children love sending and receiving text ... annoyance of their parents. But now a new study ... this technology could be used to reduce children,s chances of ... monitor and modify their own behaviors now. Recent ...
... using optical probes means that changes in cells in ... completely different light. Prof David Parker from Durham ... University, and a team of international researchers, when they ... emitted by optical probes during a series of experiments. ...
Cached Biology News:Purdue researcher invents molecule that stops SARS 2Purdue researcher invents molecule that stops SARS 3UNC study: Text messaging may help children fight off obesity 2UNC study: Text messaging may help children fight off obesity 3Luminescence shines new light on proteins 2
Bovine Serum Available Anticoagulants: N-02: Citrate N-04: Heparin (Na) N-06: K2EDTA N-08: Potassium Oxalate N-10: EDTA (Na) N-03: Alsevers N-05: ACD N-07: CPD N-09: K3EDTA N-11:...
Anti-Mouse Qa.m8, Ascites (Clone 5035-24.1) (mouse IgG3)...
... TriEx Sf9 Cells and TriEx Insect Cell ... pTriEx baculovirus constructs. This cell/medium combination has ... growth and high protein expression levels observed ... vectors. Please note that our Ready-Plaque Sf9 ...
...
Biology Products: